Biodexa Pharmaceuticals Plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was GBP 0.381 million compared to GBP 0.699 million a year ago. Net loss was GBP 7.08 million compared to GBP 7.66 million a year ago.

Basic loss per share from continuing operations was GBP 8 compared to GBP 620 a year ago. Diluted loss per share from continuing operations was GBP 8 compared to GBP 620 a year ago.